ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 737672 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 737672; 2) Community: the network communities that were significantly associated with the response to NSC 737672; 3) Molecule: the relationships between components within communities and NSC 737672; 4) MDR: the compounds that were significantly associated with the NSC 737672.

NSC Compound Enrichment Correlation
NSC 179074 Lead, bis[(2-cyanoethyl)cyclohexylcarbamodithioato-S,S']-, (T-4)- 0.0406225271888776 0.4006074
NSC 215721 Null 0.0406225271888776 0.31777182
NSC 258812 N,N-Dimethyldaunomycin hydrochloride 0.0406225271888776 0.45740282
NSC 264880 Dihydro-5-azacytidine 0.0406225271888776 0.34793107
NSC 268993 Deferoxamine hydrochloride 0.0406225271888776 0.43346259
NSC 269756 Baccharinol B4 0.0406225271888776 0.19812367
NSC 294980 N,N-Bis(2-chloroethyl)-p-toluidine 0.0406225271888776 0.61195441
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.0406225271888776 0.61232342
NSC 348401 4-(6-Thioguanine)-7-nitro-2,1,3-benzoxadiazole 0.0406225271888776 0.38736735
NSC 364830 Camptothecin Derivative 0.0406225271888776 0.63187012
Total:65  Current:50    [First] [Prev] [Next] [Last]